Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 SECTION 302 CERTIFICATION - PROLUNG INC | f10q063013_ex31z1.htm |
| EX-32.1 - EXHIBIT 32.1 SECTION 906 CERTIFICATION - PROLUNG INC | f10q063013_ex32z1.htm |
| EX-31.2 - EXHIBIT 31.2 SECTION 302 CERTIFICATION - PROLUNG INC | f10q063013_ex31z2.htm |
| EXCEL - IDEA: XBRL DOCUMENT - PROLUNG INC | Financial_Report.xls |
| 10-Q - FORM 10-Q QUARTERLY REPORT JUNE 30, 2013 - PROLUNG INC | f10q063013_10q.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
The undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that this Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Fresh Medical Laboratories, Inc..
Date: October 17, 2013
/s/ Steven Eror
Steven Eror
Acting Chief Financial Officer